BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 17545702)

  • 1. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
    Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
    AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.
    Lisco A; Grivel JC; Biancotto A; Vanpouille C; Origgi F; Malnati MS; Schols D; Lusso P; Margolis LB
    J Virol; 2007 Jan; 81(2):708-17. PubMed ID: 17065205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.
    Rajan D; Wildum S; Rücker E; Schindler M; Kirchhoff F
    AIDS; 2006 Apr; 20(6):831-6. PubMed ID: 16549966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
    Grivel JC; Margolis LB
    Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.
    Karlsson I; Grivel JC; Chen SS; Karlsson A; Albert J; Fenyö EM; Margolis LB
    J Virol; 2005 Sep; 79(17):11151-60. PubMed ID: 16103166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6.
    Grivel JC; Ito Y; Fagà G; Santoro F; Shaheen F; Malnati MS; Fitzgerald W; Lusso P; Margolis L
    Nat Med; 2001 Nov; 7(11):1232-5. PubMed ID: 11689888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines.
    Ito Y; Grivel JC; Chen S; Kiselyeva Y; Reichelderfer P; Margolis L
    J Infect Dis; 2004 Feb; 189(3):506-14. PubMed ID: 14745709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5delta32) and normal human lymphoid tissue.
    Malkevitch N; McDermott DH; Yi Y; Grivel JC; Schols D; De Clercq E; Murphy PM; Glushakova S; Collman RG; Margolis L
    Virology; 2001 Mar; 281(2):239-47. PubMed ID: 11277696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4.
    Taub DD; Mikovits JA; Nilsson G; Schaffer EM; Key ML; Petrow-Sadowski C; Ruscetti FW
    Cell Immunol; 2004 Aug; 230(2):65-80. PubMed ID: 15598422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.
    Margolis LB; Glushakova S; Grivel JC; Murphy PM
    J Clin Invest; 1998 May; 101(9):1876-80. PubMed ID: 9576751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission.
    Groot F; van Capel TM; Schuitemaker J; Berkhout B; de Jong EC
    Retrovirology; 2006 Aug; 3():52. PubMed ID: 16916447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection.
    Schmitt N; Nugeyre MT; Scott-Algara D; Cumont MC; Barré-Sinoussi F; Pancino G; Israël N
    AIDS; 2006 Feb; 20(4):533-42. PubMed ID: 16470117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
    Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
    J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice.
    Baenziger S; Tussiwand R; Schlaepfer E; Mazzucchelli L; Heikenwalder M; Kurrer MO; Behnke S; Frey J; Oxenius A; Joller H; Aguzzi A; Manz MG; Speck RF
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15951-6. PubMed ID: 17038503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV-1 replication in human lymphoid tissues ex vivo by measles virus.
    Grivel JC; García M; Moss WJ; Margolis LB
    J Infect Dis; 2005 Jul; 192(1):71-8. PubMed ID: 15942896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages.
    Kedzierska K; Crowe SM; Turville S; Cunningham AL
    Rev Med Virol; 2003; 13(1):39-56. PubMed ID: 12516061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segregation of R5 and X4 HIV-1 variants to memory T cell subsets differentially expressing CD62L in ex vivo infected human lymphoid tissue.
    Gondois-Rey F; Grivel JC; Biancotto A; Pion M; Vigne R; Margolis LB; Hirsch I
    AIDS; 2002 Jun; 16(9):1245-9. PubMed ID: 12045489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
    J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.